RDA Financial Network’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.18M Buy
8,419
+1,236
+17% +$548K 0.91% 27
2026
Q1
$3.21M Buy
7,183
+344
+5% +$160K 0.8% 26
2025
Q4
$3.1M Buy
6,839
+130
+2% +$56K 0.75% 29
2025
Q3
$2.63M Buy
6,709
+1,858
+38% +$776K 0.65% 33
2025
Q2
$2.16M Sell
4,851
-207
-4% -$95.4K 0.58% 43
2025
Q1
$2.45M Buy
5,058
+41
+0.8% +$19.1K 0.73% 35
2024
Q4
$2.02M Sell
5,017
-2,375
-32% -$1.1M 0.59% 48
2024
Q3
$3.44M Buy
7,392
+523
+8% +$251K 1.07% 21
2024
Q2
$3.22M Buy
6,869
+4,587
+201% +$1.99M 1.05% 22
2024
Q1
$954K Buy
2,282
+569
+33% +$241K 0.33% 88
2023
Q4
$697K Buy
1,713
+338
+25% +$125K 0.26% 94
2023
Q3
$478K Buy
1,375
+336
+32% +$118K 0.21% 112
2023
Q2
$366K Buy
1,039
+170
+20% +$57.3K 0.15% 140
2023
Q1
$274K Buy
+869
New +$261K 0.12% 171

Other funds holding VRTX

RDA Financial Network's VRTX Position: Q2 2026 in Review

RDA Financial Network increased its Vertex Pharmaceuticals (VRTX) stake by 17% in Q2 2026, buying an estimated $548K and bringing the position to 8,419 shares worth $4.18M. The position accounts for 0.91% of the portfolio, ranked #27.

RDA Financial Network first reported a position in VRTX in Q1 2023 and has held it in 14 quarters since. 245 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • RDA Financial Network held 8,419 shares of Vertex Pharmaceuticals worth $4.18M as of Q2 2026.
  • RDA Financial Network bought 1,236 Vertex Pharmaceuticals shares in Q2 2026, an estimated $548K.
  • Vertex Pharmaceuticals made up 0.91% of RDA Financial Network's portfolio in Q2 2026, its #27 holding.
  • RDA Financial Network first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • 245 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on RDA Financial Network's 13F filing for Q2 2026, filed 6 Jul 2026.